Kimberly-Clark Corporation (BVMF:KMBB34)

Elevation Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	634	1,021	1,093	427	270	303
Short-Term Investments	-	186	157	-	-	-
Cash & Short-Term Investments	634	1,207	1,250	427	270	303
Cash Growth	-45.49%	-3.44%	192.74%	58.15%	-10.89%	-31.45%
Accounts Receivable	2,007	1,855	1,985	2,091	2,037	2,082
Other Receivables	-	154	150	189	170	153
Receivables	2,007	2,009	2,135	2,280	2,207	2,235
Inventory	1,558	1,822	1,955	2,269	2,239	1,903
Prepaid Expenses	-	303	252	-	-	-
Other Current Assets	1,358	239	111	753	849	733
Total Current Assets	5,557	5,580	5,703	5,729	5,565	5,174
Property, Plant & Equipment	6,317	7,926	8,363	8,360	8,585	8,582
Long-Term Investments	359	314	306	238	290	300
Goodwill	1,836	1,964	2,085	2,074	1,840	1,895
Other Intangible Assets	81	87	197	851	810	832
Other Long-Term Assets	2,621	675	690	718	747	740
Total Assets	16,771	16,546	17,344	17,970	17,837	17,523
Accounts Payable	3,253	3,715	3,653	3,813	3,840	3,336
Accrued Expenses	2,019	1,346	1,398	1,243	1,171	1,316
Short-Term Debt	-	3	2	362	107	214
Current Portion of Long-Term Debt	771	549	551	471	315	263
Current Portion of Leases	-	147	144	138	141	142
Current Income Taxes Payable	-	288	294	318	323	332
Other Current Liabilities	1,128	956	888	989	852	840
Total Current Liabilities	7,171	7,004	6,930	7,334	6,749	6,443
Long-Term Debt	6,507	6,859	7,386	7,787	8,107	7,886
Long-Term Leases	-	358	403	426	453	443
Long-Term Deferred Tax Liabilities	243	326	374	647	694	723
Other Long-Term Liabilities	828	381	514	422	288	295
Total Liabilities	15,368	15,571	16,276	17,270	17,100	16,654
Common Stock	1,271	473	473	473	473	473
Additional Paid-In Capital	-	862	878	679	605	657
Retained Earnings	-	9,257	8,368	8,201	7,858	7,567
Treasury Stock	-	-5,986	-5,222	-5,137	-5,183	-4,899
Comprehensive Income & Other	-	-3,766	-3,582	-3,669	-3,239	-3,172
Total Common Equity	1,271	840	915	547	514	626
Minority Interest	132	135	153	153	223	243
Shareholders' Equity	1,403	975	1,068	700	737	869
Total Liabilities & Equity	16,771	16,546	17,344	17,970	17,837	17,523
Total Debt	7,278	7,916	8,486	9,184	9,123	8,948
Net Cash (Debt)	-6,644	-6,709	-7,236	-8,757	-8,853	-8,645
Net Cash Per Share	-19.86	-19.91	-21.36	-25.89	-26.13	-25.24
Filing Date Shares Outstanding	331.9	331.68	336.88	337.51	336.99	338.36
Total Common Shares Outstanding	331.9	331.8	337	337.46	336.84	338.72
Working Capital	-1,614	-1,424	-1,227	-1,605	-1,184	-1,269
Book Value Per Share	3.83	2.53	2.72	1.62	1.53	1.85
Tangible Book Value	-646	-1,211	-1,367	-2,378	-2,136	-2,101
Tangible Book Value Per Share	-1.95	-3.65	-4.06	-7.05	-6.34	-6.20
Land	-	157	149	156	169	174
Buildings	-	2,901	3,067	3,062	2,993	2,932
Machinery	-	15,020	15,132	14,655	14,606	14,382
Construction In Progress	-	854	803	676	760	845

Source: S&P Global Market Intelligence. Standard template. Financial Sources.